Drug
Serplulimab Chemotherapy
Serplulimab Chemotherapy: highest development phase Phase 2, developed by Shanghai Henlius Biotech. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Shanghai Henlius Biotech
Trials
| Drug | Phase | Indication |
|---|---|---|
| Serplulimab + chemotherapy (carboplatin-etoposide) NCT05468489 | Phase 2 | Extensive Stage Small Cell Lung Cancer |
Latest
No recent events.
Follow Serplulimab Chemotherapy on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.